Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system
- 20 September 1999
- journal article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 39 (1-3), 5-31
- https://doi.org/10.1016/s0169-409x(99)00017-4
Abstract
No abstract availableThis publication has 119 references indexed in Scilit:
- Study on didanosine concentrations in cerebrospinal fluidInternational Journal of Clinical Pharmacy, 1995
- Evaluation of Safety and Efficacy of 3TC (Lamivudine) in Patients with Asymptomatic or Mildly Symptomatic Human Immunodeficiency Virus Infection: A Phase I/II StudyThe Journal of Infectious Diseases, 1995
- Adamantane as a Brain-Directed Drug Carrier for Poorly Absorbed Drug. 2. AZT Derivatives Conjugated with the 1-Adamantane MoietyJournal of Pharmaceutical Sciences, 1994
- Synthesis and pharmacokinetics of a dihydropyridine chemical delivery system for the antiimmunodeficiency virus agent, dideoxycytidineJournal of Medicinal Chemistry, 1993
- Brain and cerebrospinal fluid uptake of zidovudine (AZT) in rats after intravenous injectionLife Sciences, 1990
- Pharmacokinetics of 2‘,3’‐Dideoxycytidine in Patients with AIDS and Related DisordersThe Journal of Clinical Pharmacology, 1988
- AIDS dementia: Synthesis and properties of a derivative of 3′-azido-3′-deoxythymidine (AZT) that may become ‘locked’ in the central nervous systemFEBS Letters, 1988
- Survival with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987
- Intra-Blood–Brain-Barrier Synthesis of HTLV-III-Specific IgG in Patients with Neurologic Symptoms Associated with AIDS or AIDS-Related ComplexNew England Journal of Medicine, 1985
- Thymidine Transport in the Central Nervous SystemJournal of Neurochemistry, 1980